Author

Edouard Trabulsi

Professor of Urology, Thomas Jefferson University - Cited by 7,216 - Urologic oncology - Prostate Cancer - Bladder Cancer - TRUS

Biography

Dr. Edouard Trabulsi  is currently working in Professor of Urology, Jefferson Medical College, Philadelphia, PA . He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Title
Cited by
Year
Salvage low-dose-rate prostate brachytherapy: Clinical outcomes of a phase 2 trial for local recurrence after external beam radiation therapy (NRG Oncology/RTOG 0526)
J Crook, JP Rodgers, TM Pisansky, EJ Trabulsi, MB Amin, W Bice, ...International Journal of Radiation Oncology* Biology* Physics 112 (5), 1115-1122, 222
20
2022
Urothelial cancers with small cell variant histology have confirmed high tumor mutational burden, frequent TP53 and RB mutations, and a unique gene expression profile
J Hoffman-Censits, W Choi, S Pal, E Trabulsi, WK Kelly, NM Hahn, ...European Urology Oncology 4 (2), 297-300, 2021202
17
2021
Assessment of prostate cancer treatment among black and white patients during the COVID-19 pandemic
AN Bernstein, R Talwar, E Handorf, K Syed, J Danella, S Ginzburg, ...JAMA oncology 7 (10), 1467-1473, 2021202
15
2021
IL-15 superagonist NAI in BCG-unresponsive non–muscle-invasive bladder cancer
K Chamie, SS Chang, E Kramolowsky, ML Gonzalgo, PK Agarwal, ...NEJM evidence 2 (1), EVIDoa2200167, 2022202
11
2022
Pretest genetic education video versus genetic counseling for men considering prostate cancer germline testing: a patient-choice study to address urgent practice needs
J Russo, C McDougall, N Bowler, A Shimada, L Gross, C Hyatt, WK Kelly, ...JCO Precision Oncology 5, 13-1386, 2021202
7
2021
Imaging urothelial bladder cancer: A VPAC PET targeted approach
ML Thakur, SK Tripathi, LG Gomella, E Salmanoglu, S Kim, WK Kelly, ...Can. J. Urol 28, 1096-10602, 2021202
5
2021
Setting the standards: examining research productivity among academic urologists in the USA and Canada in 2019
T Chandrasekar, TM Han, L Glick, JY Leong, S Teplitsky, R Noorani, ...European Urology Focus 7 (2), 489-496, 2021202
5
2021
Helix: a digital tool to address provider needs for prostate cancer genetic testing in clinical practice
VN Giri, A Walker, L Gross, EJ Trabulsi, CD Lallas, WK Kelly, LG Gomella, ...Clinical Genitourinary Cancer 20 (2), e104-e113, 2022202
5
2022
Small cell bladder cancer response to second-line and beyond checkpoint inhibitor therapy: retrospective experience
J Hoffman-Censits, W Choi, TJ Bivalacqua, P Pierorazio, M Kates, ...Clinical genitourinary cancer 19 (2), 176-181, 2021202
4
2021
The international penile advanced cancer trial (InPACT): The first phase III trial for squamous carcinoma of the penis with regional lymph node metastases.
CA Pettaway, S Nicholson, PE Spiess, LC Pagliaro, N Watkin, J Barber, ...Journal of Clinical Oncology 40 (6_suppl), TPS7-TPS7, 2022202
3
2022
Contrast-enhanced ultrasound and shear wave elastography: novel methods for the evaluation of urethral stricture disease
PH Chung, JY Leong, P Machado, CE Wessner, EJ Trabulsi, EJ Halpern, ...The Journal of urology 207 (1), 152-160, 2022202
3
2022
Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative
Utility of PSA density in patients with PI-RADS lesions across a large multi-institutional collaborativeJ Drevik, Z Dalimov, R Uzzo, J Danella, T Guzzo, L Belkoff, J Raman, ...Urologic Oncology: Seminars and Original Investigations 40 (11), 490. e1-490. e6, 2022202
3
2022
PD03-02 Racial disparities in prostate cancer treatment in a multi-institutional regional collaborative
PD0-02 Racial disparities in prostate cancer treatment in a multi-institutional regional collaborativeA Bernstein, R Talwar, E Handorf, K Syed, J Danella, S Ginzburg, ...Journal of Urology 206 (Supplement ), e4, 2021202
3
2021
Preventing prostate biopsy complications: to augment or to swab?
L Glick, SA Vincent, D Squadron, TM Han, K Syed, JF Danella, ...Urology 155, 12-19, 2021202
3
2021
The use of individualized 3D-printed models on trainee and patient education, and surgical planning for robotic partial nephrectomies
The use of individualized D-printed models on trainee and patient education, and surgical planning for robotic partial nephrectomiesER Scott, A Singh, AM Quinn, S Morano, A Karp, K Boyd, M Ho, ...Journal of Robotic Surgery 17 (2), 465-472, 20220
3
2023
EA8185: Phase II study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), ECOG-ACRIN/nrg …
M Joshi, SE Kim, AA Solanki, DT Miyamoto, D Degraff, JW Zou, JJ Meeks, ...Journal of Clinical Oncology 39 (6_suppl), TPS500-TPS500, 010
2
2021
Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for …
S Loeb, HH Cheng, A Leader, L Gross, TS Nolasco, N Byrne, DR Wise, ...Contemporary Clinical Trials 119, 10681, 0
2
2022
Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study
KS Pohar, S Patel, Y Lotan, E Trabulsi, M Woods, T Downs, WC Huang, ...Urologic Oncology: Seminars and Original Investigations 40 (8), 38. e1-38. e6, 0
2
2022
Non-infectious complications following transrectal prostate needle biopsy–Outcomes from over 8000 procedures
A Sosenko, RG Owens, AL Yang, A Alzubaidi, T Guzzo, E Trabulsi, ...Prostate International 10 (3), 158-161, 0
2
2022
Outcomes of Active Surveillance for Men With Intermediate Risk Prostate Cancer: A Population-Based Analysis
T Chandrasekar, N Bowler, A Schneider, H Goldberg, JR Mark, ...Urology 155, 101-109, 010
2
2021

Referred From: https://scholar.google.com/citations?hl=en&user=6rLMoOMAAAAJ

Cited by
Citations 7216
h-index 46
i10-index 122
Recommended Journals
Open Access Journals